abstract |
The invention relates to the following compounds: 5 - ({3 - [(3-methylphenyl) carbonylamino] -5- [N- (6-sulphonaphthyl) carbamoyl] phenyl} -carbonylamino) -naphthalene-2-sulfonic acid; 5 - ({3 - [(4-methylphenyl) carbonylamino] -5- [N- (6-sulfonaphthyl) carbamoyl] phenyl} -carbonylamino) -naphthalene-2-sulfonic acid, and their pharmaceutically acceptable salts.It also relates to a process for the preparation of these compounds and pharmaceutical compositions containing them.Application: Use of these compounds and compositions for the treatment of hyperglycemia and diabetes. |